- ►annals.org [PDF] A Tichelli, G Socie, M Henry-Amar, J Marsh, … - Annals of internal medicine, 1999 - Am Coll Physicians André Tichelli, MD; Gérard Socié, MD; Michel Henry-Amar, MD; Judith Marsh,
MD; Jakob Passweg, MD; Hubert Schrezenmeier, MD; Shaun McCann, MD; Jill Hows,
MD; Per Ljungman, MD; Pedro Marin, MD; Aruna Raghavachar, MD; Anna ... Cited by 45 - Related articles - All 7 versions
E Di Bona, F Rodeghiero, B Bruno, A Gabbas, P … - British journal of haematology, 1999 - interscience.wiley.com About 30% of patients with severe aplastic anaemia (SAA) unresponsive to one
course of immunosuppressive (IS) therapy with antithymocyte or antilymphocyte
globulin can achieve complete or partial remission after a second IS ... Cited by 65 - Related articles - BL Direct - All 3 versions
E Gluckman, R Rokicka-Milewska, I Hann, E … - British journal of haematology, 2002 - interscience.wiley.com Summary. In patients with idiopathic severe aplastic anaemia who are treated
with immunosuppressive agents to combat T lymphocyte-mediated destruction of
haematopoietic progenitor cells, neutropenia is a major cause of infections ... Cited by 51 - Related articles - BL Direct - All 4 versions
P Scheinberg, O Nunez, C Wu, NS Young - British journal of haematology, 2006 - interscience.wiley.com Severe aplastic anaemia (SAA) can be successfully treated with immunosuppressive
therapies or haematopoietic stem cell transplantation (HSCT). Response rates
with horse anti-thymocyte globulin (h-ATG) plus ciclosporin (CsA) are about ... Cited by 30 - Related articles - BL Direct - All 4 versions
P Scheinberg, O Nunez, NS Young… - British journal of haematology, 2006 - interscience.wiley.com The management of patients with severe aplastic anaemia (SAA) who do not have a
matched sibling donor and fail a course of horse anti-thymocyte globulin
(h-ATG)/ciclosporin (CsA) is uncertain. Repeated courses of ATG-based ... Cited by 32 - Related articles - BL Direct - All 4 versions
J Marsh, H Schrezenmeier, P Marin, O Ilhan, … - Blood, 1999 - bloodjournal.hematologylibrary.org We report the results of the first prospective randomized multicenter study of
immunosuppressive treatment in patients with previously untreated nonsevere
aplastic anemia (AA) as defined by a neutrophil count of at least 0.5 × 10 ... Cited by 115 - Related articles - BL Direct - All 9 versions
H Schrezenmeier, P Marin, A Raghavachar, S … - British Journal of Haernatology, 1993 - interscience.wiley.com SummaryThis study was designed to determine the incidence of relapse and factors
predictive for relapse in 719 patients with severe aplastic anaemia (SAA) after
immunosuppressive treatment (IS). Patients developing myelodysplasia or ... Cited by 78 - Related articles - BL Direct - All 3 versions
A Tichelli, J Passweg, C Nissen, M Bargetzi, … - British journal of haematology, 1998 - interscience.wiley.com In a single-centre study the feasibility and efficacy of repeated antilymphocyte
globulin (ALG) for patients with severe aplastic anaemia (SAA) not responding to
an initial ALG treatment or relapsing after initial response to ALG was ... Cited by 65 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org N Frickhofen, H Heimpel, JP Kaltwasser, H … - Blood, 2003 - bloodjournal.hematologylibrary.org Because HSCT cures aplastic anemia, it is the treatment of choice for young
patients with suitable stem cell donors. HLA-matched related donors are widely
accepted as stem cell donors, 2 whereas unrelated donor HSCT still carries ... Cited by 118 - Related articles - BL Direct - All 9 versions
- ►hematologylibrary.org M Teramura, A Kimura, S Iwase, Y Yonemura, … - Blood, 2007 - bloodjournal.hematologylibrary.org We report the results of a randomized study to elucidate whether addition of
granulocyte colony-stimulating factor (G-CSF) to immunosuppressive therapy is
valuable for the treatment of severe aplastic anemia (SAA) in adults. A ... Cited by 21 - Related articles - BL Direct - All 2 versions
